Production (Stage)
HCW Biologics Inc.
HCWB
$5.49
-$0.09-1.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.45M | 2.57M | 3.50M | 3.92M | 3.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.45M | 2.57M | 3.50M | 3.92M | 3.93M |
| Cost of Revenue | 1.10M | 1.61M | 2.36M | 2.70M | 2.76M |
| Gross Profit | 345.70K | 959.40K | 1.13M | 1.22M | 1.16M |
| SG&A Expenses | 20.66M | 24.15M | 29.54M | 30.54M | 21.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.40M | 32.05M | 39.28M | 41.10M | 31.78M |
| Operating Income | -25.95M | -29.48M | -35.79M | -37.18M | -27.85M |
| Income Before Tax | -24.75M | -30.02M | -37.33M | -38.37M | -27.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.75 | -30.02 | -37.33 | -38.37 | -27.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.75M | -30.02M | -37.33M | -38.37M | -27.39M |
| EBIT | -25.95M | -29.48M | -35.79M | -37.18M | -27.85M |
| EBITDA | -24.59M | -28.30M | -35.01M | -36.25M | -26.77M |
| EPS Basic | -23.53 | -23.68 | -32.36 | -33.73 | -22.36 |
| Normalized Basic EPS | -14.64 | -14.71 | -19.36 | -20.22 | -13.98 |
| EPS Diluted | -23.53 | -23.68 | -32.36 | -33.73 | -22.36 |
| Normalized Diluted EPS | -14.64 | -14.71 | -19.36 | -20.22 | -13.98 |
| Average Basic Shares Outstanding | 47.62M | 40.17M | 40.01M | 39.97M | 39.92M |
| Average Diluted Shares Outstanding | 47.62M | 40.17M | 40.01M | 39.97M | 39.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |